Breakthrough Targeted Therapies in Inflammatory Bowel Disease: A Focus on JAK Inhibitors
JAK inhibitors have emerged as a promising targeted therapy for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
JAK inhibitors have emerged as a promising targeted therapy for inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
Integrative nutritional therapies, including the low FODMAP diet, probiotics, and prebiotics, are increasingly used to manage IBS.